{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T13:00:35Z","timestamp":1786194035428,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T00:00:00Z","timestamp":1654300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001688","name":"International Centre for Genetic Engineering and Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["202926\/Z\/16\/Z"],"award-info":[{"award-number":["202926\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFD0500300"],"award-info":[{"award-number":["2016YFD0500300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["CRP\/CHN19-02"],"award-info":[{"award-number":["CRP\/CHN19-02"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018316","name":"Institute of Chemical Biology, National Hellenic Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/D524840\/1"],"award-info":[{"award-number":["BB\/D524840\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP \/F500416\/1"],"award-info":[{"award-number":["EP \/F500416\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.apsb.2022.06.002","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T17:30:43Z","timestamp":1654795843000},"page":"3924-3933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Acrylamide fragment inhibitors that induce unprecedented conformational distortions in enterovirus 71 3C and SARS-CoV-2 main protease"],"prefix":"10.1016","volume":"12","author":[{"given":"Bo","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory B.","family":"Craven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengjiao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Chesti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6447-8578","authenticated-orcid":false,"given":"Xinran","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma S.","family":"Child","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9760-3638","authenticated-orcid":false,"given":"Rhodri M.L.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3692-3099","authenticated-orcid":false,"given":"Alan","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2022.06.002_bib1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2174\/1389202916666150707160613","article-title":"RNA Viruses: RNA roles in pathogenesis, coreplication and viral load","volume":"16","author":"Poltronieri","year":"2015","journal-title":"Curr Genom"},{"key":"10.1016\/j.apsb.2022.06.002_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2018.17","article-title":"Epidemiological characteristics of human-infective RNA viruses","volume":"5","author":"Woolhouse","year":"2018","journal-title":"Sci Data"},{"key":"10.1016\/j.apsb.2022.06.002_bib3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3345\/kjp.2016.59.10.395","article-title":"Enterovirus 71 infection and neurological complications","volume":"59","author":"Lee","year":"2016","journal-title":"Korean J Pediatr"},{"key":"10.1016\/j.apsb.2022.06.002_bib4","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1303224","article-title":"An inactivated enterovirus 71 vaccine in healthy children","volume":"370","author":"Li","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2022.06.002_bib5","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.46.1800590","article-title":"Severe enterovirus A71 associated hand, foot and mouth disease, Vietnam, 2018: preliminary report of an impending outbreak","volume":"23","author":"Nhan","year":"2018","journal-title":"Euro Surveill"},{"key":"10.1016\/j.apsb.2022.06.002_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12929-019-0560-7","article-title":"Antivirals and vaccines for enterovirus A71","volume":"26","author":"Lin","year":"2019","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.apsb.2022.06.002_bib7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/v8030082","article-title":"Roles of the Picornaviral 3C proteinase in the viral life cycle and host cells","volume":"8","author":"Sun","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.apsb.2022.06.002_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1517\/13543770903460323","article-title":"Picornaviral 3C protease inhibitors and the dual 3C protease\/coronaviral 3C-like protease inhibitors","volume":"20","author":"Wang","year":"2010","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.apsb.2022.06.002_bib9","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1128\/AAC.43.10.2444","article-title":"In\u00a0vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease","volume":"43","author":"Patick","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2022.06.002_bib10","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1128\/AAC.47.12.3907-3916.2003","article-title":"Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers","volume":"47","author":"Hayden","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.apsb.2022.06.002_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.apsb.2022.06.002_bib12","unstructured":"Classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern. Available from: https:\/\/www.who.int\/news\/item\/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern."},{"key":"10.1016\/j.apsb.2022.06.002_bib13","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.1085658","article-title":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs","volume":"300","author":"Anand","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.apsb.2022.06.002_bib14","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1073\/pnas.0510851103","article-title":"Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme","volume":"103","author":"Ratia","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2022.06.002_bib15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd3410","article-title":"The resurgence of covalent drugs","volume":"10","author":"Singh","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2022.06.002_bib16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/1078155214561281","article-title":"A review of a novel, Bruton's tyrosine kinase inhibitor, ibrutinib","volume":"22","author":"Lee","year":"2016","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.apsb.2022.06.002_bib17","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1039\/C7MD90012K","article-title":"The structure-guided discovery of osimertinib: the first U.S. FDA approved mutant selective inhibitor of EGFR T790M","volume":"8","author":"Butterworth","year":"2017","journal-title":"MedChemComm"},{"key":"10.1016\/j.apsb.2022.06.002_bib18","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1021\/acs.jmedchem.6b00788","article-title":"Covalent modifiers: a chemical perspective on the reactivity of \u03b1,\u03b2-unsaturated carbonyls with thiols via hetero-michael addition reactions","volume":"60","author":"Jackson","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2022.06.002_bib19","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1038\/s41467-020-18709-w","article-title":"Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease","volume":"11","author":"Douangamath","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2022.06.002_bib20","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1002\/anie.201711825","article-title":"High-throughput kinetic analysis for target-directed covalent ligand discovery","volume":"57","author":"Craven","year":"2018","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.apsb.2022.06.002_bib21","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1002\/cbic.202000457","article-title":"Multiparameter kinetic analysis for covalent fragment optimization by using quantitative irreversible tethering (qIT)","volume":"21","author":"Craven","year":"2020","journal-title":"Chembiochem"},{"key":"10.1016\/j.apsb.2022.06.002_bib22","article-title":"Daily briefing: pfizer's COVID pill looks promising","author":"Graham","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2022.06.002_bib23","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s13238-021-00883-2","article-title":"Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332","volume":"13","author":"Zhao","year":"2022","journal-title":"Protein Cell"},{"key":"10.1016\/j.apsb.2022.06.002_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1021\/acsmedchemlett.8b00270","article-title":"Acrylamide functional group incorporation improves drug-like properties: an example with EGFR inhibitors","volume":"10","author":"Wu","year":"2019","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.apsb.2022.06.002_bib25","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S1359-6446(03)02831-9","article-title":"A 'rule of three' for fragment-based lead discovery?","volume":"8","author":"Congreve","year":"2003","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2022.06.002_bib26","doi-asserted-by":"crossref","first-page":"10072","DOI":"10.1021\/jm501412a","article-title":"Chemical and computational methods for the characterization of covalent reactive groups for the prospective design of irreversible inhibitors","volume":"57","author":"Flanagan","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2022.06.002_bib27","doi-asserted-by":"crossref","first-page":"10021","DOI":"10.1128\/JVI.05107-11","article-title":"Crystal structures of\u00a0enterovirus 71 3C protease complexed with rupintrivir reveal the\u00a0roles of catalytically important residues","volume":"85","author":"Wang","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2022.06.002_bib28","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.abb4489","article-title":"Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease","volume":"368","author":"Dai","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.apsb.2022.06.002_bib29","doi-asserted-by":"crossref","first-page":"12725","DOI":"10.1021\/acs.jmedchem.0c01063","article-title":"Discovery of ketone-based covalent inhibitors of coronavirus 3CL proteases for the potential therapeutic treatment of COVID-19","volume":"63","author":"Hoffman","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2022.06.002_bib30","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0040-4039(01)98993-2","article-title":"Calculation of carbon-sulphur bond lengths","volume":"9","author":"Trinajsti\u0107","year":"1968","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.apsb.2022.06.002_bib31","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1002\/ptr.6998","article-title":"In silico and\u00a0in\u00a0vitro evaluation of kaempferol as a potential inhibitor of the SARS-CoV-2 main protease (3CLpro)","volume":"35","author":"Khan","year":"2021","journal-title":"Phytother Res"},{"key":"10.1016\/j.apsb.2022.06.002_bib32","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s12539-021-00447-2","article-title":"In silico mutagenesis-based remodelling of SARS-CoV-1 peptide (ATLQAIAS) to inhibit SARS-CoV-2: structural-dynamics and free energy calculations","volume":"13","author":"Khan","year":"2021","journal-title":"Interdiscip Sci"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383522002684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383522002684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:56:06Z","timestamp":1761929766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383522002684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2211383522002684"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2022.06.002","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.11.06.370916","asserted-by":"object"}]},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acrylamide fragment inhibitors that induce unprecedented conformational distortions in enterovirus 71 3C and SARS-CoV-2 main protease","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2022.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}